251 related articles for article (PubMed ID: 11884563)
1. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.
Faber M; Pulmanausahakul R; Hodawadekar SS; Spitsin S; McGettigan JP; Schnell MJ; Dietzschold B
J Virol; 2002 Apr; 76(7):3374-81. PubMed ID: 11884563
[TBL] [Abstract][Full Text] [Related]
2. In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife.
Dietzschold ML; Faber M; Mattis JA; Pak KY; Schnell MJ; Dietzschold B
Vaccine; 2004 Dec; 23(4):518-24. PubMed ID: 15530701
[TBL] [Abstract][Full Text] [Related]
3. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
Foley HD; McGettigan JP; Siler CA; Dietzschold B; Schnell MJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14680-5. PubMed ID: 11114165
[TBL] [Abstract][Full Text] [Related]
4. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
5. Development of rabies DNA vaccine using a recombinant plasmid.
Rai N; Kaushik P; Rai A
Acta Virol; 2005; 49(3):207-10. PubMed ID: 16178518
[TBL] [Abstract][Full Text] [Related]
6. A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity.
Faber M; Faber ML; Papaneri A; Bette M; Weihe E; Dietzschold B; Schnell MJ
J Virol; 2005 Nov; 79(22):14141-8. PubMed ID: 16254349
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response.
Rath A; Choudhury S; Batra D; Kapre SV; Rupprecht CE; Gupta SK
Virus Res; 2005 Nov; 113(2):143-52. PubMed ID: 15978691
[TBL] [Abstract][Full Text] [Related]
8. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
[TBL] [Abstract][Full Text] [Related]
9. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector.
Xuan X; Tuchiya K; Sato I; Nishikawa Y; Onoderaz Y; Takashima Y; Yamamoto A; Katsumata A; Iwata A; Ueda S; Mikami T; Otsuka H
Vaccine; 1998; 16(9-10):969-76. PubMed ID: 9682345
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of single and dual siRNAs targeting rabies virus glycoprotein and nucleoprotein genes for inhibition of virus multiplication in vitro.
Meshram CD; Singh NK; Sonwane AA; Pawar SS; Mishra BP; Chaturvedi VK; Saini M; Singh RP; Gupta PK
Arch Virol; 2013 Nov; 158(11):2323-32. PubMed ID: 23754741
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant replication-defective adenovirus based rabies vaccine].
Li WH; Zhang Y; Wang SH; Liu L; Yang F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
[TBL] [Abstract][Full Text] [Related]
13. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
[TBL] [Abstract][Full Text] [Related]
14. Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV.
Wirblich C; Schnell MJ
J Virol; 2011 Jan; 85(2):697-704. PubMed ID: 21068252
[TBL] [Abstract][Full Text] [Related]
15. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.
Morimoto K; Hooper DC; Spitsin S; Koprowski H; Dietzschold B
J Virol; 1999 Jan; 73(1):510-8. PubMed ID: 9847357
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
[TBL] [Abstract][Full Text] [Related]
18. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.
Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR
Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942
[TBL] [Abstract][Full Text] [Related]
19. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice.
Yan X; Prosniak M; Curtis MT; Weiss ML; Faber M; Dietzschold B; Fu ZF
J Neurovirol; 2001 Dec; 7(6):518-27. PubMed ID: 11704884
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.
Pulmanausahakul R; Faber M; Morimoto K; Spitsin S; Weihe E; Hooper DC; Schnell MJ; Dietzschold B
J Virol; 2001 Nov; 75(22):10800-7. PubMed ID: 11602721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
